Quick Answer
REGENERON PHARMACEUTICALS, INC. reported Shares Outstanding of 90.69 million shares for fiscal year 2011.
REGENERON PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2011 | 90.69M | +4.0% |
| 2010 | 87.24M | +10.6% |
| 2009 | 78.86M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2012 | 94.41M | +4.4% | -99.9% |
| June 30, 2012 | 93.94B | +104961.5% | +1.0% |
| March 31, 2012 | 92.97B | +104893.2% | +102411.1% |
| December 31, 2011 | 90.69M | +4.0% | +0.3% |
| September 30, 2011 | 90.42M | +13.0% | +1.1% |
| June 30, 2011 | 89.42M | +11.9% | +1.0% |
| March 31, 2011 | 88.55M | — | +1.5% |
| December 31, 2010 | 87.24M | +10.6% | +9.0% |
- REGENERON PHARMACEUTICALS, INC. showed an increase of +4.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2009–2011 period, REGENERON PHARMACEUTICALS, INC.’s shares outstanding has grown by 15.0% (from 78.86 million shares to 90.69 million shares).
- The most recent figure is from REGENERON PHARMACEUTICALS, INC.’s fiscal year 2011 report (Form 10-K), filed with the SEC on February 21, 2012.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: